Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
This target is a pseudogene with sequence similarity to part of ribosomal protein L3 (RPL3), encoded by Ensembl as ENSG00000234648. Pseudogenes such as this often arise from duplication or retrotransposition events resulting in non-functional gene copies that do not encode active proteins. In the human genome, many ribosomal protein genes have dispersed pseudogenes that are functionally inactive[5][3][4]. Although RPL3 itself encodes a critical component of the 60S ribosomal subunit involved in protein synthesis, its pseudogenes—including ENSG00000234648—have no established biological activity. There is no evidence this pseudogene plays a role in disease, functions as a receptor, or serves as a target for therapeutic intervention. For structured drug discovery and biomedical studies, this entry should be considered non-targetable.
None. There are no mechanisms of action for drug targeting as it is not an active target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pseudogene similar to part of ribosomal protein L3 (ENSG00000234648).